Temozolomide (Temodar)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Temozolomide (Temodar), covering 2013-06-19 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor [EARLY_Phase 1]